NeoGenomics Inc.

NEO | NASDAQ

Price Alert Chart Builder DCF Calculator

$18.99

-$0.42 (-2.16%)

Sep 22, 2026, 2:46 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-2.16%

(1D)

Rating

Updated: Sep 19, 2026

39.5

Fundamentals Average

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $487.95M

1D Range

18.99 19.60

52W Range

7.07 20.05

Valuation (TTM)

PE -9.71

PB 0.63

EV/EBITDA 62.20

Valuation (NTM)

Forward PE 56.73

Forward PEG -0.12

Price Target $22

Cash Flow

FCF Yield -1.5%

SBC Adj. FCF Yield -7.1%

SBC Impact -382.8%

Margins

Gross Margin 42.9%

Operating Margin -8.6%

FCF Margin -1.0%

Growth (CAGR)

Revenue 3Y | 5Y 11.6% | 9.4%

Dil EPS 3Y | 5Y 18.0% | 21.4%

FCF 3Y | 5Y 59.7% | 56.0%

Returns

ROA -3.8%

ROE -6.3%

ROIC -5.0%

Financial Health

Net Debt

$234.13M

Current Ratio 3.60

Interest Coverage -25.64

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

NeoGenomics, Inc. specializes in providing cancer-focused diagnostic and testing services through an extensive network of laboratories located across the United States, Europe, and Asia. The company o...

Sector Healthcare

Industry Medical - Diagnostics & Research

Employees 2,500

IPO Date Mar 15, 2004

Website www.neogenomics.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Oct 27, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$22

Upside

+15.85%

Buy (5)

Hold (0)

Sell (0)

Analyst Details ➞